• 

  Sputnik V vaccine to be available through Apollo Hospitals from June 2nd week

  India | May 27, 2021 18:06 IST

  As the country ramp up efforts to vaccinate majority of population as soon as possible, Apollo Hospitals Executive Vice-chairperson Shobana Kamineni on Thursday said that Sputnik V, the third vaccine approved in India will be available through the Apollo Hospitals from the second week of June."

• 

  Counter opposition's rant on vaccination with facts and scientific data: PM Modi

  India | May 27, 2021 11:58 IST

  Prime Minister Narendra Modi has asked Health Minister Harsh Vardhan to counter opposition parties' narratives on vaccination with facts.

• 

  India becomes second country after US to cross 20 crore cumulative vaccination coverage

  India | May 26, 2021 16:41 IST

  As the country faces the deadly second wave of coronavirus, India has become the second country after the United States to cross 20 crore cumulative COVID-19 vaccination coverage.

• 

  Sputnik V makers have agreed to supply vaccine to Delhi: CM Kejriwal

  India | May 26, 2021 14:18 IST

  Delhi CM Arvind Kejriwal has said Sputnik V manufacturers have agreed to supply the drug to the national capital. Sputnik V is a Russian anti-Covid vaccine.

• 

  Sputnik V production begins; RDIF, Panacea Biotec to make 10 crore doses per year

  India | May 24, 2021 16:05 IST

  RDIF and Panacea Biotec have launched the production of Sputnik V vaccine in India. India's Panacea Biotec will now produce 100 million doses of Sputnik V per year.

• 

  More pharma firms should be allowed to make Covid vaccine: Gadkari

  India | May 19, 2021 12:31 IST

  There are two vaccine makers in the country currently -- Bharat Biotech and Serum Institute of India -- which are manufacturing Covaxin and Covishield, respectively. Only three vaccines have so far been approved to be sold in India --- Covaxin, Coveshield and Sputnik V.

• 

  COVID-19 Vaccine: Sputnik debuts on Cowin app at Rs 1250

  Health | May 18, 2021 13:29 IST

  Sputnik V, the Russian COVID-19 vaccine being produced in India by Dr Reddy's Laboratory has made its debut on the CoWIN platform on May 18. Reportedly, it is available at a price of Rs 1250. 

• 

  Explore possibility of Sputnik V procurement: Punjab CM Amarinder Singh

  India | May 16, 2021 18:59 IST

  Addressing the virtual Covid review meeting, he said 1 lakh doses received initially for 18-44 category had almost been completely utilized.

• 

  "Sputnik V is Russian-Indian vaccine", says Russian Ambassador to India

  India | May 16, 2021 9:41 IST

  Russian Ambassador to India, N Kudashev has termed Sputnik V as a "Russian-Indian vaccine"

• 

  Second batch of Russian COVID-19 vaccine Sputnik V arrives in Hyderabad

  India | May 16, 2021 8:54 IST

  Sputnik V has become the first foreign-made vaccine to be used in India contributing to the world's largest COVID-19 vaccination campaign. Inoculations with Sputnik V in Hyderabad started Friday followed by the arrival of the first batch of the vaccine in India on May 1, 2021.

• 

  Delhi govt writes to Dr Reddy's for 67 lakh doses of Sputnik V vaccine

  India | May 15, 2021 21:17 IST

  Amid vaccine shortage faced by Delhi, Chief Minister Arvind Kejriwal on Saturday said his government has written to Dr Reddy's Laboratories for supply of around 67 lakh doses of Russian COVID-19 vaccine Sputnik V.

Advertisement
• 

  Sputnik V Light, Russia's single-dose Covid vaccine, likely to be launched in India soon

  India | May 14, 2021 21:18 IST

  Sputnik V Light, Russia's single-dose vaccine for Covid19 is expected to be launched in India soon, informed Russia Direct Investment Fund CEO Kirill Dmitriev on Friday.

• 

  Russia's Sputnik V vaccine priced at Rs 995 per dose in India, 1st shot given in Hyderabad

  Business | May 14, 2021 15:06 IST

  The first consignment of imported doses of the Sputnik V vaccine landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13, 2021.

• 

  Sputnik V Phase 3 trial clear, transparent: Russian scientists

  India | May 13, 2021 19:20 IST

  A team of scientists from universities in the US, the Netherlands, Italy, France and Russia had earlier flagged concerns over Sputnik V Phase 3 trial, specifically on discrepancies in data sharing, trial protocols, inconsistencies in data reported and numerical results.

• 

  Sputnik V vaccine to be available in market from next week: Govt

  India | May 13, 2021 18:07 IST

  As India battles with the second wave of coronavirus, NITI Aayog member VK Paul on Thursday said that the Sputnik V vaccine will be available in the market by next week.

• 

  Will Sputnik Light, Russia's single dose Covid vaccine come to India? What Govt said

  India | May 07, 2021 23:07 IST

  Russia has approved Sputnik Light Covid vaccine which claims to have an efficacy of nearly 80 per cent.

• 

  'Sputnik Light' single dose Covid vaccine with 80% efficacy approved by Russia

  Good News | May 06, 2021 18:51 IST

  Russian health officials have approved a single-dose version of the Sputnik V vaccine. Sputnik Light has showed nearly 80 per cent efficacy in tests.

• 

  Looking forward to expand cooperation with India to contain COVID-19: Russia

  India | May 01, 2021 23:59 IST

  As the first batch of 150,000 doses of Russian-made Sputnik V COVID-19 vaccine arrived in India, Russia on Saturday said it was looking forward to further expand bilateral and multilateral cooperation with New Delhi to contain the coronavirus pandemic.

• 

  First consignment of Sputnik V vaccines from Russia arrive in Hyderabad

  India | May 01, 2021 23:38 IST

  As India battles the second wave of coronavirus, the first consignment of Russia's Sputnik V vaccines arrived in Hyderabad.

• 

  PM Modi calls Russian President Putin, thanks him for extending support to India's Covid war

  India | April 28, 2021 22:09 IST

  The two leaders discussed the evolving Covid-19 pandemic situation. President Putin expressed solidarity with the people and government of India and conveyed that Russia would extend all possible support in this regard.